Doctor sounds alarm on quality, efficacy of Alzheimer’s supplement
By
Kristen Fischer
Feb 27, 2024
When it was sold as a prescription generic drug, galantamine was labeled accurately and it wasn’t contaminated. But that wasn’t the case when galantamine was sold as an over-the-counter dietary supplement,...
Clinical briefs for Tuesday, Sept. 5
By
Kristen Fischer
Sep 05, 2023
Amazon Prime, GoodRx can save millions on generics … Cognitive deficits after COVID-19 linked to clotting proteins … Mushroom component in psilocybin helps depression, study finds … Some airports...
Cognitive decline prevention may start in the gut, study suggests
By
Kristen Fischer
Jul 25, 2023
Probiotics could aid in preventing cognitive decline that happens during aging, according to a study released at the American Society for Nutrition conference this week in Boston. The research could make...
Clinical briefs for Friday, Nov. 3
By
Kristen Fischer
Nov 03, 2023
Study: Stem cells could reverse osteoarthritis … About 25% of stents aren’t necessary, data shows … Insulin can stay at room temp for months … Could infection control standards get weaker? …...
Clinical briefs for Friday, Aug. 25
By
Kristen Fischer
Aug 25, 2023
No change in prescribing rates for dental-related antibiotics … Spotting adenine in urine could signal kidney failure in people with diabetes … Gene variant that boosts Parkinson’s risk found in...
Clinical briefs for Monday, Oct. 2
By
Kristen Fischer
Oct 02, 2023
COVID-19, RSV vaccine hesitancy concerns infectious disease experts … HHS invests $104 million in antibiotic resistance initiative … People with these neurons may thwart cognitive decline … Dietary...
Clinical briefs for Wed., Sept. 13
By
Kristen Fischer
Sep 13, 2023
Racial disparities emerge in people with frontotemporal dementia … Docs find success with new treatments for persistent C. difficile … Inverse vaccine looks good so far to reverse MS, type 1 diabetes...
Researchers spot whose cognitive ability may shift during dementia trials
By
Kristen Fischer
Jan 17, 2024
People who changed cognitive status from impaired to normal during clinical trials tend to be younger, have better cognition and be negative for amyloid biomarkers, according to a new study.
Adult ADHD tied to dementia risk, study finds
By
Kristen Fischer
Oct 20, 2023
Adults with attention-deficit/hyperactivity disorder (ADHD) are almost three times more likely to develop dementia compared to their peers, a new study suggests. Taking medication could help, as there...
Race, ethnicity help determine which controllable risk factors for dementia have biggest impacts
By
Kristen Fischer
Jan 18, 2024
Controllable risk factors that factor into Alzheimer’s or dementia cases play varying roles based on someone’s race and ethnicity, a new study shows.